Table of Content

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Blood & Plasma Components Market
5. Voice of Customer
6. Global Blood & Plasma Components Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
6.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
6.2.2. By Application (Hematology, Solid Tumor Management, Others)
6.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
6.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Blood & Plasma Components Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
7.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
7.2.2. By Application (Hematology, Solid Tumor Management, Others)
7.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
7.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Blood & Plasma Components Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Canada Blood & Plasma Components Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Mexico Blood & Plasma Components Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products
7.3.3.2.2. By Application
7.3.3.2.3. By End User
8. Europe Blood & Plasma Components Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
8.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
8.2.2. By Application (Hematology, Solid Tumor Management, Others)
8.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
8.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Blood & Plasma Components Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Germany Blood & Plasma Components Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. United Kingdom Blood & Plasma Components Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Italy Blood & Plasma Components Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Spain Blood & Plasma Components Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Asia-Pacific Blood & Plasma Components Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
9.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
9.2.2. By Application (Hematology, Solid Tumor Management, Others)
9.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
9.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Blood & Plasma Components Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. India Blood & Plasma Components Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Japan Blood & Plasma Components Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. South Korea Blood & Plasma Components Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Products
9.3.4.2.2. By Application
9.3.4.2.3. By End User
9.3.5. Australia Blood & Plasma Components Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Products
9.3.5.2.2. By Application
9.3.5.2.3. By End User
10. South America Blood & Plasma Components Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
10.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
10.2.2. By Application (Hematology, Solid Tumor Management, Others)
10.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
10.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood & Plasma Components Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Argentina Blood & Plasma Components Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Colombia Blood & Plasma Components Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Middle East and Africa Blood & Plasma Components Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
11.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
11.2.2. By Application (Hematology, Solid Tumor Management, Others)
11.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
11.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Blood & Plasma Components Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Products
11.3.1.2.2. By Application
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Blood & Plasma Components Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Products
11.3.2.2.2. By Application
11.3.2.2.3. By End User
11.3.3. UAE Blood & Plasma Components Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Products
11.3.3.2.2. By Application
11.3.3.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. CSL Limited
14.2. Grifols S.A.
14.3. ADMA Biologics, Inc.
14.4. Takeda Pharmaceutical Company Limited
14.5. Octapharma AG
14.6. Kedrion S.p.A
14.7. Emergent BioSolutions Inc.
14.8. Bio Products Laboratory Ltd.
14.9. LFB S.A.
14.10. Versiti, Inc.
15. Strategic Recommendations